Fund Manager Talk | Valuation sanity coming back, go against the tide: Alok Ranjan
Alok Ranjan, Senior Fund Manager at ITI Mutual Fund, sees valuations normalizing and advises diversifying portfolios amid ...
Gland Pharma gets EIR from USFDA for Pashamylaram facility
Gland Pharma announced that it has received an establishment inspection report (EIR) from the U.S. Food and Drug Administration (USFDA) for its Pashamylaram facility at Hyderabad.
Even with the new rules, SEBI still looking at ways to grow the F&O ecosystem, says Ananth Narayan
SEBI issued a new framework for the index-derivatives segment, including reducing contracts with weekly expiries, increasing ...